Effect of facet joint injection in lumbar spinal stenosis: Experience of Rheumatology Hospital Unit of Cotonou (Benin)  by Zomalheto, Zavier et al.
The Egyptian Rheumatologist (2014) 36, 101–104Egyptian Society for Joint Diseases and Arthritis
The Egyptian Rheumatologist
www.rheumatology.eg.net
www.sciencedirect.comORIGINAL ARTICLEEﬀect of facet joint injection in lumbar
spinal stenosis: Experience of Rheumatology
Hospital Unit of Cotonou (Benin)* Corresponding author. Tel.: +229 95 01 77 79.
E-mail addresses: zozaher@yahoo.fr (Z. Zomalheto), cosherv12@
yahoo.fr (M. Gounongbe´), avimamartin@yahoo.fr (M. Avimadje´).
Peer review under responsibility of Egyptian Society for Joint Diseases
and Arthritis.
Production and hosting by Elsevier
1110-1164  2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society for Joint Diseases and Arthritis.
http://dx.doi.org/10.1016/j.ejr.2013.10.001Open access under CC BY-NC-ND license.Zavier Zomalheto a,*, Marcelle Gounongbe´ b, Martin Avimadje´ ba Rheumatology Department of the National Center University Hospital of Cotonou (Benin), BP: 2139 Abomey Calavi, Benin
b Rheumatology Department of the National Center University Hospital of Cotonou (Benin), BP:188 Cotonou, BeninReceived 1 September 2013; accepted 1 October 2013
Available online 9 November 2013KEYWORDS
Facet joint injection;
Facet joint arthrosis;
Lumbar spinal stenosisAbstract Aim of the work: To evaluate the effect of facet joint injection in patients with lumbar
spinal stenosis due to facet joint arthrosis in the Rheumatology Department of National Hospital
University-Hubert Koutoukou Maga of Cotonou (Benin).
Patients and methods: A prospective case-control study was conducted from January 2011 to
June 2013. The selected patients suffered from lumbar spinal stenosis due to facet joint arthrosis
and received two corticosteroid facet joint injections at two week intervals compared to the con-
trol-group with the same disease. Demographic data, clinical parameters and outcomes in six months
were collected. The primary endpoint was the reduction of visual analogue score (VAS) for pain.
Results: Sixty-four patients received a facet joint injection against 65 patients in the control
group. The mean age was 67.03 ± 12.1 and 66.02 ± 13.7 and the sex ratio was 0.64 and 0.71, respec-
tively in the ‘‘injection group’’ and ‘‘control group.’’ All patients had a VAS > 4. At one, three and
six months, 53 (82.2%), 41 (64.06) and 26 (40.62) patients had, respectively more than 75% pain
reduction against 27 (41.53%), 15 (23.08) and 7 (10.77) patients in the control group (p< 0.01).
Patients in the injection group were ﬁve times more improved than the control group at six months
with OR= 5.67 95% CI [2.07, 6.16].
Conclusion: This work shows the effectiveness of facet joint injections to relieve pain due to facet
joint arthrosis that continued at six months of follow up.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society for Joint Diseases and
Arthritis. Open access under CC BY-NC-ND license.
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The responsibility of facet joints in the genesis of low back
pain is known since the early twentieth century [1]. The prev-
alence of facet joint syndrome is estimated to be between
7.7% and 75% of chronic low back pain [2–4]. Since the work
of Maigne [5] and Mooney and Robertson [6], facet joint cor-
ticosteroid injections are frequently performed to try to relieve
chronic low back pain patients. These facet joint injections
have become common in a large majority of radiology or
Rheumatology centers. Their technique is relatively well codi-
ﬁed, especially at the lumbar level. However, the effectiveness
of facet joint injection is controversial [7].
This study aims to evaluate the effect of facet joint injection
in patients with lumbar spinal stenosis due to facet joint
arthrosis in the Rheumatology Hospital Unit of National Uni-
versity Hospital Hubert Maga Koutoukou (NHU-HKM) of
Cotonou.
2. Patients and methods
This prospective case-control study was conducted from Janu-
ary 2011 to June 2013 in the Rheumatology Hospital Unit of
National Hospital University Hubert Koutoukou Maga of
Cotonou. Ethical approval was obtained for this work.
The Patients were recruited for 12 months and those who
took part met the following criteria:
- Having consulted in the Rheumatology Hospital Unit dur-
ing the study period.
- Have suffered from chronic back pain (pain duration was
more than three months) with or without associated radic-
ular pain or claudication.
- Have had lumbar spinal canal stenosis due to facet joint
arthrosis conﬁrmed by CT with anteroposterior diameter
of the spinal canal less than 13 mm at the level of the lum-
bar vertebrae.
- Having respected the appointments of follow-up visit for
6 months.
Two groups of patients were formed according to the crite-
ria. The ﬁrst group called ‘‘injection group’’ received medical
treatment in the form of analgesics and anti-inﬂammatory
drugs associated with two facet joint injections with cortivazol
(ALTIMR) at two weeks interval. The ‘‘control-group’’ re-
ceived only medical treatment. The analgesics used included
tramadol or acetaminophen only or combined with codeineFigure 1 CT scan of a patient with lumbar spinal canaland the anti-inﬂammatory drugs used were diclofenac, keto-
profen or piroxicam.
1.5 ml corresponding to 3.75 mg dose of Cortivazol (AL-
TIMR) was administered. One or two injections were done in
the facet joints L3–L4, L4–L5, and L5–S1 unilaterally or bilat-
erally depending on the damage. Inﬁltrations were performed
by two experienced Rheumatologists specialized in interven-
tional Rheumatology. For the injection, we used a procedure
described by Chevrot et al. [8]: Patients were prone with a pil-
low under the belly (kyphosis). The operator marks the punc-
ture below the lower pole of the inferior apophyseal process or
above the projection of the pedicle anatomically. Using a 22
gauge needle, a puncture is made vertically crossing the capsule
by the operator. The needle is penetrated by a slightly upward
inclination until the bone is reached guided by ﬂuoroscopy in
the facet joints L3–L4, L4–L5 or L5–S1 (Figs. 1 and 2). Local
anesthesia was not used for this study.
Analgesic treatment was maintained throughout the study
period while the anti-inﬂammatory drugs were stopped after
two weeks of continuous intake. We did not notify any compli-
cations after the procedure.
Data collection was initially done using a survey form which
were identiﬁed the general characteristics (age, sex, occupation,
and address), visual analog scale (VAS) for overall lumbar and
radicular pain, presence of claudication and/or radicular pain of
the two groups. The VAS for pain of patients was recorded in
three follow-up visits at one, three and six months.
The primary endpoint was the reduction of visual analogue
score (DVAS). The severity of pain was recorded on a 100 mm
VAS where 0 means no pain and 100 represents the most
severe pain. The outcome was considered satisfactory when
the reduction of VAS (DVAS) >75% and poor when
DVAS < 25%.
Statistical analysis: Data were analyzed using epidata and
SPSS17.0 software. Chi-square test was used to compare the
differences between both groups. Statistical signiﬁcance was
set at p< 0.05. The data were expressed as frequency, range
mean ± standard deviation (S.D.), odds ratio and 95%
conﬁdence interval (CI).3. Results
3.1. Sociodemographic characteristics
Sixty-four patients received a facet joint injection against 65
patients in the control group. The mean age wasstenosis at the level of L5 due to facet joint arthrosis.
Figure 2 Right L5–S1 facet joint injection with cortivazol guided
by ﬂuoroscopy.
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0.71 respectively in the ‘‘injection and control groups. All
patients had a VAS > 4. The characteristics of both groups
are summarized in Table 1.
3.2. Outcomes of DVAS among the two groups
Patients in the ‘‘injection’’ group were ﬁve times more im-
proved than the control group for six months with
OR= 5.67 95% CI [2.07, 6.16]. Table 2 and Fig. 3 summarize
variation of DVAS and odd-ratio.Table 1 Characteristics of the two groups of patients suffering from
Characteristic Injection group
Number 64
Mean age (years) 67.03 ± 12.1 [34–88]
Sex-ratio (male/female) 25/39 (0.64)
4 < VAS < 7 37
VAS> 7 27
Presence of nerve root pain 39
Presence of claudication 34
VAS: Visual Analogue Score.
Table 2 Outcome of DVAS at 1, 3 and 6 months in the two groups o
arthrosis.
Evaluation criteria Injection group N (%) Contr
1 month
DVASP 75% 53 (82.82) 27 (41
DVAS< 25% 11 (17.18) 39 (58
3 months
DVASP 75% 41 (64.06) 15 (23
DVAS< 25% 23 (35.94) 50 (76
6 months
DVASP 75% 26 (40.62) 7 (10.7
DVAS< 25% 38 (59.38) 58 (89
Total 64 65
DVAS: Reduction of the Visual Analogue Score.4. Discussion
This study presents selection bias. Indeed, the study was not
randomized and patients in the control group were those
who refused the injection or those who did not have the means
to afford the injection under ﬂuoroscopy whose total cost was
high (about ﬁfty thousand African Financial Community
‘CFA’ francs). In the literature, in reference to intra-articular
injections, there are 2 randomized trials; one high quality ran-
domized [9] and the other study by Fuchs et al. is a moderate
quality one [10].
In the study of Carette et al. [9], the number of patients sig-
niﬁcantly improved in those who received corticosteroid injec-
tions of the facet joints at different time points (1, 3 and
6 months) than the control group (which received anesthetic
injection). Their results were negative at six months. On the
other hand, in the six non-randomized studies reviewed by
Falco et al. in reference to facet joint injection, 5 results were
positive [11].
In the review of literature presented by Clere et al. [12], they
showed that it is difﬁcult to compare results obtained by the
teams who have published on the inﬁltration of facet joint,
due to variability in patient inclusion criteria, study methods
and criteria especially those for the assessment used. Relief is
obtained in 16–63% of cases if the clinical criteria are well
deﬁned, with an average of 50% [13–15]. These results are
congruent with ours where about half of the patients retained
a beneﬁcial effect of inﬁltration signiﬁcantly after six months
with an OR= 5.67 95% CI [2.07–16.06].lumbar spinal stenosis due to facet joint arthrosis.
Control group p
65
66.02 ± 13.7 [32–84] 11.6
27/38 (0.71) 5.01
41 2.4
24
47
42
f patients suffering from lumbar spinal stenosis due to facet joint
ol group N (%) Odds-ratio (95% IC) p
.53) 6.96 [2.88–17.14] <0.01
.47)
.08) 5.94 [2.58–13.89] <0.01
.92)
7) 5.67 [2.07–16.06] <0.01
.23) 16.06]
Figure 3 Evolution of the mean VAS for pain in the injection
and control groups of patients with facet joint arthrosis.
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as the main criterion, but with great variability both in quan-
titative terms (signiﬁcant relief: 33%, 50%, 75%) and in terms
of quality, which makes comparisons difﬁcult [12–15].
The short duration of the evaluation period performed in
our study can be criticized. Studies with a longer term (1-year
follow-up) are needed to ensure the extra gain. Indeed, Bani
and associates showed in their study a negative result after
1 year [16].
In Conclusion this work shows the effectiveness of facet
joint injections to relieve pain due to facet joint arthrosis that
continued at six months of follow up. Others studies of one
year duration are recommended to assess the additional effect
of the injection in our country.
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